Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review)

Carlucci A, Adornetto A, Scorziello A, Viggiano D, Foca M, Cuomo O, Annunziato L, Gottesman M and Feliciello A: Proteolysis of AKAP121 regulates mitochondrial activity during cellular hypoxia and brain ischaemia. EMBO J. 27:1073–1084. 2008. View Article : Google Scholar : PubMed/NCBI

Haidarali S, Patil CR, Ojha S, Mohanraj R, Arya DS and Goyal SN: Targeting apoptotic pathways in myocardial infarction: Attenuated by phytochemicals. Cardiovasc Hematol Agents Med Chem. 12:72–85. 2014. View Article : Google Scholar

Kuznetsov AV, Javadov S, Margreiter R, Grimm M, Hagenbuchner J and Ausserlechner MJ: The role of mitochon-dria in the mechanisms of cardiac ischemia-reperfusion injury. Antioxidants (Basel). 8:4542019. View Article : Google Scholar

Yang M, Linn BS, Zhang Y and Ren J: Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 1865:2293–2302. 2019. View Article : Google Scholar : PubMed/NCBI

Chouchani ET, Pell VR, James AM, Work LM, Saeb-Parsy K, Frezza C, Krieg T and Murphy MP: A unifying mechanism for mitochondrial superoxide production during ischemia-reperfu-sion injury. Cell Metab. 23:254–263. 2016. View Article : Google Scholar : PubMed/NCBI

Lesnefsky EJ, Chen Q, Tandler B and Hoppel CL: Mitochondrial dysfunction and myocardial ischemia-reperfusion: Implications for novel therapies. Annu Rev Pharmacol Toxicol. 57:535–565. 2017. View Article : Google Scholar

Eltzschig HK and Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med. 17:1391–1401. 2011. View Article : Google Scholar : PubMed/NCBI

Wang W, Fernandez-Sanz C and Sheu SS: Regulation of mitochondrial bioenergetics by the non-canonical roles of mitochondrial dynamics proteins in the heart. Biochim Biophys Acta Mol Basis Dis. 1864:1991–2001. 2018. View Article : Google Scholar

Spinelli JB and Haigis MC: The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 20:745–754. 2018. View Article : Google Scholar : PubMed/NCBI

Niemann B, Schwarzer M and Rohrbach S: Heart and mitochondria: Pathophysiology and implications for cardiac surgeons. Thorac Cardiovasc Surg. 66:11–19. 2018. View Article : Google Scholar

Bender DA: Oxidative phosphorylation. Encyclopedia of food sciences and nutrition. Caballero B: 2nd edition. Academic Press; Oxford; pp. 4295–4301. 2003, View Article : Google Scholar

Murphy MP: How mitochondria produce reactive oxygen species. Biochem J. 417:1–13. 2009. View Article : Google Scholar

Guzy RD, Sharma B, Bell E, Chandel NS and Schumacker PT: Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol. 28:718–731. 2008. View Article : Google Scholar :

Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, et al: Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 515:431–435. 2014. View Article : Google Scholar : PubMed/NCBI

Pell VR, Chouchani ET, Frezza C, Murphy MP and Krieg T: Succinate metabolism: A new therapeutic target for myocardial reperfusion injury. Cardiovasc Res. 111:134–141. 2016. View Article : Google Scholar : PubMed/NCBI

Bugger H and Pfeil K: Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol Basis Dis. 1866:1657682020. View Article : Google Scholar : PubMed/NCBI

Boengler K, Lochnit G and Schulz R: Mitochondria 'THE' target of myocardial conditioning. Am J Physiol Heart Circ Physiol. 315:H1215–H1231. 2018. View Article : Google Scholar

Lin MT and Beal MF: Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 443:787–795. 2006. View Article : Google Scholar : PubMed/NCBI

Marzetti E, Csiszar A, Dutta D, Balagopal G, Calvani R and Leeuwenburgh C: Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: From mechanisms to therapeutics. Am J Physiol Heart Circ Physiol. 305:H459–H476. 2013. View Article : Google Scholar : PubMed/NCBI

Nordberg J and Arner ES: Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med. 31:1287–1312. 2001. View Article : Google Scholar : PubMed/NCBI

Judge S and Leeuwenburgh C: Cardiac mitochondrial bioenergetics, oxidative stress, and aging. Am J Physiol Cell Physiol. 292:C1983–C1992. 2007. View Article : Google Scholar : PubMed/NCBI

Zhang W, Chen C, Wang J, Liu L, He Y and Chen Q: Mitophagy in cardiomyocytes and in platelets: A major mechanism of cardioprotection against ischemia/reperfusion injury. Physiology (Bethesda). 33:86–98. 2018.

Tahrir FG, Langford D, Amini S, Mohseni Ahooyi T and Khalili K: Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease. J Cell Physiol. 234:8122–8133. 2019. View Article : Google Scholar :

Paradies G, Petrosillo G, Paradies V and Ruggiero FM: Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium. 45:643–650. 2009. View Article : Google Scholar : PubMed/NCBI

Kay L, Nicolay K, Wieringa B, Saks V and Wallimann T: Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ. J Biol Chem. 275:6937–6944. 2000. View Article : Google Scholar : PubMed/NCBI

Dolder M, Wendt S and Wallimann T: Mitochondrial creatine kinase in contact sites: Interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage. Biol Signals Recept. 10:93–111. 2001. View Article : Google Scholar : PubMed/NCBI

Arslan F, de Kleijn DP and Pasterkamp G: Innate immune signaling in cardiac ischemia. Nat Rev Cardiol. 8:292–300. 2011. View Article : Google Scholar : PubMed/NCBI

James AM, Hoogewijs K, Logan A, Hall AR, Ding S, Fearnley IM and Murphy MP: Non-enzymatic N-acetylation of lysine residues by AcetylCoA often occurs via a proximal S-acetylated thiol intermediate sensitive to glyoxalase II. Cell Rep. 18:2105–2112. 2017. View Article : Google Scholar : PubMed/NCBI

Wagner GR, Bhatt DP, O'Connell TM, Thompson JW, Dubois LG, Backos DS, Yang H, Mitchell GA, Ilkayeva OR, Stevens RD, et al: A class of reactive Acyl-CoA species reveals the non-enzymatic origins of protein acylation. Cell Metab. 25:823–837.e8. 2017. View Article : Google Scholar : PubMed/NCBI

Wagner GR and Hirschey MD: Nonenzymatic protein acylation as a carbon stress regulated by sirtuin deacylases. Mol Cell. 54:5–16. 2014. View Article : Google Scholar : PubMed/NCBI

Yang SJ, Choi JM, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW and Park CY: Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. J Nutr Biochem. 25:66–72. 2014. View Article : Google Scholar

Carraro M and Bernardi P: Calcium and reactive oxygen species in regulation of the mitochondrial permeability transition and of programmed cell death in yeast. Cell Calcium. 60:102–107. 2016. View Article : Google Scholar : PubMed/NCBI

Giorgio V, Guo L, Bassot C, Petronilli V and Bernardi P: Calcium and regulation of the mitochondrial permeability transition. Cell Calcium. 70:56–63. 2018. View Article : Google Scholar

Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T and Tsujimoto Y: Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 434:652–658. 2005. View Article : Google Scholar : PubMed/NCBI

Martin JL, Gruszczyk AV, Beach TE, Murphy MP and Saeb-Parsy K: Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury. Pediatr Nephrol. 34:1167–1174. 2019. View Article : Google Scholar :

Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM and Hausenloy DJ: Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 121:2012–2022. 2010. View Article : Google Scholar : PubMed/NCBI

Din S, Mason M, Volkers M, Johnson B, Cottage CT, Wang Z, Joyo AY, Quijada P, Erhardt P, Magnuson NS, et al: Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation. Proc Natl Acad Sci USA. 110:5969–5974. 2013. View Article : Google Scholar : PubMed/NCBI

Balaban RS: Cardiac energy metabolism homeostasis: Role of cytosolic calcium. J Mol Cell Cardiol. 34:1259–1271. 2002. View Article : Google Scholar : PubMed/NCBI

Nan J, Zhu W, Rahman MS, Liu M, Li D, Su S, Zhang N, Hu X, Yu H, Gupta MP and Wang J: Molecular regulation of mitochondrial dynamics in cardiac disease. Biochim Biophys Acta Mol Cell Res. 1864:1260–1273. 2017. View Article : Google Scholar : PubMed/NCBI

Sharp WW, Fang YH, Han M, Zhang HJ, Hong Z, Banathy A, Morrow E, Ryan JJ and Archer SL: Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: Therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. FASEB J. 28:316–326. 2014. View Article : Google Scholar :

Murphy MP and Hartley RC: Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov. 17:865–886. 2018. View Article : Google Scholar : PubMed/NCBI

Thomas LW and Ashcroft M: Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria. Cell Mol Life Sci. 76:1759–1777. 2019. View Article : Google Scholar : PubMed/NCBI

Song M, Mihara K, Chen Y, Scorrano L and Dorn GW II: Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 21:273–286. 2015. View Article : Google Scholar : PubMed/NCBI

Chen Y, Liu Y and Dorn GW II: Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res. 109:1327–1331. 2011. View Article : Google Scholar : PubMed/NCBI

Song M, Gong G, Burelle Y, Gustafsson AB, Kitsis RN, Matkovich SJ and Dorn GW II: Interdependence of Parkin-Mediated mitophagy and mitochondrial fission in adult mouse hearts. Circ Res. 117:346–351. 2015. View Article : Google Scholar : PubMed/NCBI

Sabbah HN: Targeting the mitochondria in heart failure: A trans-lational perspective. JACC Basic Transl Sci. 5:88–106. 2020. View Article : Google Scholar : PubMed/NCBI

Ikeda Y, Shirakabe A, Brady C, Zablocki D, Ohishi M and Sadoshima J: Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardio-vascular system. J Mol Cell Cardiol. 78:116–122. 2015. View Article : Google Scholar

Große L, Wurm CA, Bruser C, Neumann D, Jans DC and Jakobs S: Bax assembles into large ring-like structures remodeling the mitochondrial outer membrane in apoptosis. EMBO J. 35:402–413. 2016. View Article : Google Scholar

Kim H, Scimia MC, Wilkinson D, Trelles RD, Wood MR, Bowtell D, Dillin A, Mercola M and Ronai ZeA: Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell. 44:532–544. 2011. View Article : Google Scholar : PubMed/NCBI

Marin W: A-kinase anchoring protein 1 (AKAP1) and its role in some cardiovascular diseases. J Mol Cell Cardiol. 138:99–109. 2020. View Article : Google Scholar

Disatnik MH, Ferreira JC, Campos JC, Gomes KS, Dourado PM, Qi X and Mochly-Rosen D: Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J Am Heart Assoc. 2:e0004612013. View Article : Google Scholar : PubMed/NCBI

Ikeda Y, Shirakabe A, Maejima Y, Zhai P, Sciarretta S, Toli J, Nomura M, Mihara K, Egashira K, Ohishi M, et al: Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ Res. 116:264–278. 2015. View Article : Google Scholar

Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ and Mihara K: Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol. 191:1141–1158. 2010. View Article : Google Scholar : PubMed/NCBI

Jin Q, Li R, Hu N, Xin T, Zhu P, Hu S, Ma S, Zhu H, Ren J and Zhou H: DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways. Redox Biol. 14:576–587. 2018. View Article : Google Scholar

Li J, Li Y, Jiao J, Wang J, Li Y, Qin D and Li P: Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol Cell Biol. 34:1788–1799. 2014. View Article : Google Scholar : PubMed/NCBI

Jiang X, Jiang H, Shen Z and Wang X: Activation of mitochon-drial protease OMA1 by Bax and Bak promotes cytochrome c release during apoptosis. Proc Natl Acad Sci USA. 111:14782–14787. 2014. View Article : Google Scholar

Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV and Orekhov AN: The role of mitochondrial dysfunction in cardio-vascular disease: A brief review. Ann Med. 50:121–127. 2018. View Article : Google Scholar

Minoia M, Boncoraglio A, Vinet J, Morelli FF, Brunsting JF, Poletti A, Krom S, Reits E, Kampinga HH and Carra S: BAG3 induces the sequestration of proteasomal clients into cytoplasmic puncta: Implications for a proteasome-to-autophagy switch. Autophagy. 10:1603–1621. 2014. View Article : Google Scholar : PubMed/NCBI

Hammerling BC and Gustafsson AB: Mitochondrial quality control in the myocardium: Cooperation between protein degradation and mitophagy. J Mol Cell Cardiol. 75:122–130. 2014. View Article : Google Scholar : PubMed/NCBI

Kocaturk NM and Gozuacik D: Crosstalk between mammalian autophagy and the Ubiquitin-Proteasome system. Front Cell Dev Biol. 6:1282018. View Article : Google Scholar : PubMed/NCBI

Escobar-Henriques M, Altin S and Brave FD: Interplay between the ubiquitin proteasome system and mitochondria for protein homeostasis. Curr Issues Mol Biol. 35:35–58. 2020. View Article : Google Scholar

Nishida K and Otsu K: Sterile inflammation and degradation systems in heart failure. Circ J. 81:622–628. 2017. View Article : Google Scholar : PubMed/NCBI

Li J, Horak KM, Su H, Sanbe A, Robbins J and Wang X: Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest. 121:3689–3700. 2011. View Article : Google Scholar : PubMed/NCBI

Yu X and Kem DC: Proteasome inhibition during myocardial infarction. Cardiovasc Res. 85:312–320. 2010. View Article : Google Scholar

Zhou H and Toan S: Pathological roles of mitochondrial oxidative stress and mitochondrial dynamics in cardiac microvascular Ischemia/Reperfusion injury. Biomolecules. 10:852020. View Article : Google Scholar :

Morales PE, Arias-Duran C, Avalos-Guajardo Y, Aedo G, Verdejo HE, Parra V and Lavandero S: Emerging role of mitophagy in cardiovascular physiology and pathology. Mol Aspects Med. 71:1008222020. View Article : Google Scholar

Chen Y and Dorn GW II: PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science. 340:471–475. 2013. View Article : Google Scholar : PubMed/NCBI

Siddall HK, Yellon DM, Ong SB, Mukherjee UA, Burke N, Hall AR, Angelova PR, Ludtmann MH, Deas E, Davidson SM, et al: Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury. PLoS One. 8:e624002013. View Article : Google Scholar : PubMed/NCBI

Kubli DA, Zhang X, Lee Y, Hanna RA, Quinsay MN, Nguyen CK, Jimenez R, Petrosyan S, Murphy AN and Gustafsson AB: Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J Biol Chem. 288:915–926. 2013. View Article : Google Scholar :

Zhou H, Zhang Y, Hu S, Shi C, Zhu P, Ma Q, Jin Q, Cao F, Tian F and Chen Y: Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J Pineal Res. 63:e124132017. View Article : Google Scholar

Zhang T, Xue L, Li L, Tang C, Wan Z, Wang R, Tan J, Tan Y, Han H, Tian R, et al: BNIP3 protein suppresses PINK1 kinase proteolytic cleavage to promote mitophagy. J Biol Chem. 291:21616–21629. 2016. View Article : Google Scholar : PubMed/NCBI

Wu W, Lin C, Wu K, Jiang L, Wang X, Li W, Zhuang H, Zhang X, Chen H, Li S, et al: FUNDC1 regulates mitochondrial dynamics at the ER-mitochondrial contact site under hypoxic conditions. EMBO J. 35:1368–1384. 2016. View Article : Google Scholar : PubMed/NCBI

Tahrir FG, Knezevic T, Gupta MK, Gordon J, Cheung JY, Feldman AM and Khalili K: Evidence for the role of BAG3 in mitochondrial quality control in cardiomyocytes. J Cell Physiol. 232:797–805. 2017. View Article : Google Scholar :

Schänzer A, Rupp S, Graf S, Zengeler D, Jux C, Akinturk H, Gulatz L, Mazhari N, Acker T, Van Coster R, et al: Dysregulated autophagy in restrictive cardiomyopathy due to Pro209Leu mutation in BAG3. Mol Genet Metab. 123:388–399. 2018. View Article : Google Scholar : PubMed/NCBI

Ong SB, Kalkhoran SB, Hernandez-Resendiz S, Samangouei P, Ong SG and Hausenloy DJ: Mitochondrial-shaping proteins in cardiac health and disease-the long and the short of it! Cardiovasc Drugs Ther. 31:87–107. 2017. View Article : Google Scholar : PubMed/NCBI

Kuznetsov AV and Margreiter R: Heterogeneity of mitochondria and mitochondrial function within cells as another level of mitochondrial complexity. Int J Mol Sci. 10:1911–1929. 2009. View Article : Google Scholar : PubMed/NCBI

Geng Y, Hu Y, Wang H, Shi S, Shi J and Qiu Z: Deficiency of interfibrillar mitochondria in post-acute myocardial infarction heart failure. Pak J Pharm Sci. 30:1089–1094. 2017.PubMed/NCBI

Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al: Heart disease and stroke statistics-2020 update: A report from the American heart association. Circulation. 141:e139–e596. 2020. View Article : Google Scholar : PubMed/NCBI

Zhu SC, Chen C, Wu YN, Ahmed M, Kitmitto A, Greenstein AS, Kim SJ, Shao YF and Zhang YH: Cardiac complex II activity is enhanced by fat and mediates greater mitochondrial oxygen consumption following hypoxic re-oxygenation. Pflugers Arch. 472:367–374. 2020. View Article : Google Scholar : PubMed/NCBI

Kohlhauer M, Pell VR, Burger N, Spiroski AM, Gruszczyk A, Mulvey JF, Mottahedin A, Costa ASH, Frezza C, Ghaleh B, et al: Protection against cardiac ischemia-reperfusion injury by hypothermia and by inhibition of succinate accumulation and oxidation is additive. Basic Res Cardiol. 114:182019. View Article : Google Scholar : PubMed/NCBI

Turton JA, Fagg R, Sones WR, Williams TC and Andrews CM: Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse. Int J Exp Pathol. 87:101–112. 2006. View Article : Google Scholar : PubMed/NCBI

Ambekar CS, Lee JS, Cheung BM, Chan LC, Liang R and Kumana CR: Chloramphenicol succinate, a competitive substrate and inhibitor of succinate dehydrogenase: Possible reason for its toxicity. Toxicol In Vitro. 18:441–447. 2004. View Article : Google Scholar : PubMed/NCBI

Sala-Mercado JA, Wider J, Undyala VV, Jahania S, Yoo W, Mentzer RM Jr, Gottlieb RA and Przyklenk K: Profound cardio-protection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation. 122(11 Suppl): S179–S184. 2010. View Article : Google Scholar : PubMed/NCBI

Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cocheme HM, Reinhold J, Lilley KS, et al: Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med. 19:753–759. 2013. View Article : Google Scholar : PubMed/NCBI

Xu A, Szczepanek K, Hu Y, Lesnefsky EJ and Chen Q: Cardioprotection by modulation of mitochondrial respiration during ischemia-reperfusion: Role of apoptosis-inducing factor. Biochem Biophys Res Commun. 435:627–633. 2013. View Article : Google Scholar : PubMed/NCBI

Brand MD, Goncalves RL, Orr AL, Vargas L, Gerencser AA, Borch Jensen M, Wang YT, Melov S, Turk CN, Matzen JT, et al: Suppressors of superoxide-H₂O₂ production at site I(Q) of mitochondrial complex I protect against stem cell hyperplasia and ischemia-reperfusion injury. Cell Metab. 24:582–592. 2016. View Article : Google Scholar : PubMed/NCBI

Zozina VI, Covantev S, Goroshko OA, Krasnykh LM and Kukes VG: Coenzyme Q10 in cardiovascular and metabolic diseases: Current state of the problem. Curr Cardiol Rev. 14:164–174. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang ZW, Xu XC, Liu T and Yuan S: Mitochondrion-permeable antioxidants to treat ROS-Burst-mediated acute diseases. Oxid Med Cell Longev. 2016:68595232016.

Di Lorenzo A, Iannuzzo G, Parlato A, Cuomo G, Testa C, Coppola M, D'Ambrosio G, Oliviero DA, Sarullo S, Vitale G, et al: Clinical evidence for Q10 coenzyme supple-mentation in heart failure: From energetics to functional improvement. J Clin Med. 9:12662020. View Article : Google Scholar

Mortensen AL, Rosenfeldt F and Filipiak KJ: Effect of coen-zyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial. Cardiol J. 26:147–156. 2019.

Reily C, Mitchell T, Chacko BK, Benavides G, Murphy MP and Darley-Usmar V: Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol. 1:86–93. 2013. View Article : Google Scholar : PubMed/NCBI

Smith RA and Murphy MP: Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci. 1201:96–103. 2010. View Article : Google Scholar : PubMed/NCBI

Lee FY, Shao PL, Wallace CG, Chua S, Sung PH, Ko SF, Chai HT, Chung SY, Chen KH, Lu HI, et al: Combined therapy with SS31 and mitochondria mitigates myocardial ischemia-reperfusion injury in rats. Int J Mol Sci. 19:27822018. View Article : Google Scholar :

Kloner RA, Hale SL, Dai W, Gorman RC, Shuto T, Koomalsingh KJ, Gorman JH III, Sloan RC, Frasier CR, Watson CA, et al: Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide. J Am Heart Assoc. 1:e0016442012. View Article : Google Scholar : PubMed/NCBI

Botker HE, Cabrera-Fuentes HA, Ruiz-Meana M, Heusch G and Ovize M: Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction. J Cell Mol Med. 24:2717–2729. 2020. View Article : Google Scholar : PubMed/NCBI

Mailloux RJ: Application of mitochondria-targeted pharmaceuticals for the treatment of heart disease. Curr Pharm Des. 22:4763–4779. 2016. View Article : Google Scholar : PubMed/NCBI

van Empel VP, Bertrand AT, van Oort RJ, van der Nagel R, Engelen M, van Rijen HV, Doevendans PA, Crijns HJ, Ackerman SL, Sluiter W and De Windt LJ: EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol. 48:824–832. 2006. View Article : Google Scholar : PubMed/NCBI

Baguisi A, Casale RA, Kates SA, Lader AS, Stewart K and Beeuwkes R III: CMX-2043 efficacy in a rat model of cardiac ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther. 21:563–569. 2016. View Article : Google Scholar : PubMed/NCBI

Tsubota K: The first human clinical study for NMN has started in Japan. NPJ Aging Mech Dis. 2:160212016. View Article : Google Scholar

Hong W, Mo F, Zhang Z, Huang M and Wei X: Nicotinamide mononucleotide: A promising molecule for therapy of diverse diseases by targeting NAD+ metabolism. Front Cell Dev Biol. 8:2462020. View Article : Google Scholar : PubMed/NCBI

Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, Shigaki S, Ono T, Yukioka H, et al: Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. 67:153–160. 2020. View Article : Google Scholar

Bendickova K, Tidu F and Fric J: Calcineurin-NFAT signalling in myeloid leucocytes: New prospects and pitfalls in immuno-suppressive therapy. EMBO Mol Med. 9:990–999. 2017. View Article : Google Scholar : PubMed/NCBI

Ottani F, Latini R, Staszewsky L, La Vecchia L, Locuratolo N, Sicuro M, Masson S, Barlera S, Milani V, Lombardi M, et al: Cyclosporine a in reperfused myocardial infarction: The multicenter, controlled, open-label CYCLE trial. J Am Coll Cardiol. 67:365–374. 2016. View Article : Google Scholar : PubMed/NCBI

Ikeda G, Matoba T, Nakano Y, Nagaoka K, Ishikita A, Nakano K, Funamoto D, Sunagawa K and Egashira K: Nanoparticle-mediated targeting of cyclosporine a enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening. Sci Rep. 6:204672016. View Article : Google Scholar : PubMed/NCBI

Jahandiez V, Cour M, Bochaton T, Abrial M, Loufouat J, Gharib A, Varennes A, Ovize M and Argaud L: Fast therapeutic hypothermia prevents post-cardiac arrest syndrome through cyclophilin D-mediated mitochondrial permeability transition inhibition. Basic Res Cardiol. 112:352017. View Article : Google Scholar : PubMed/NCBI

Parodi-Rullán RM, Soto-Prado J, Vega-Lugo J, Chapa-Dubocq X, Díaz-Cordero SI and Javadov S: Divergent effects of cyclophilin-D inhibition on the female rat heart: Acute versus chronic post-myocardial infarction. Cell Physiol Biochem. 50:288–303. 2018. View Article : Google Scholar : PubMed/NCBI

Khuchua Z, Glukhov AI, Strauss AW and Javadov S: Elucidating the beneficial role of PPAR agonists in cardiac diseases. Int J Mol Sci. 19:34642018. View Article : Google Scholar :

Lalloyer F and Staels B: Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol. 30:894–899. 2010. View Article : Google Scholar : PubMed/NCBI

Viscomi C, Bottani E, Civiletto G, Cerutti R, Moggio M, Fagiolari G, Schon EA, Lamperti C and Zeviani M: In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis. Cell Metab. 14:80–90. 2011. View Article : Google Scholar : PubMed/NCBI

Madrid-Miller A, Moreno-Ruiz LA, Borrayo-Sánchez G, Almeida-Gutiér rez E, Martínez-Gómez DF and Jáuregui-Aguilar R: Ipact of bezafibrate treatment in patients with hyperfibrinogenemia and ST-elevation acute myocardial infarction: A randomized clinical trial. Cir Cir. 78:229–237. 2010.PubMed/NCBI

Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, McVeety JC and Horwitz RI: Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke. Stroke. 34:1431–1436. 2003. View Article : Google Scholar : PubMed/NCBI

Liu J and Wang LN: Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack. Cochrane Database Syst Rev. 12:CD0106932017.PubMed/NCBI

Palee S, Weerateerangkul P, Surinkeaw S, Chattipakorn S and Chattipakorn N: Effect of rosiglitazone on cardiac electrophysi-ology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart. Exp Physiol. 96:778–789. 2011. View Article : Google Scholar : PubMed/NCBI

Nissen SE and Wolski K: Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 356:2457–2471. 2007. View Article : Google Scholar : PubMed/NCBI

Sunaga H, Koitabashi N, Iso T, Matsui H, Obokata M, Kawakami R, Murakami M, Yokoyama T and Kurabayashi M: Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts. Sci Rep. 9:118412019. View Article : Google Scholar : PubMed/NCBI

Zhang DS, Liang GY, Liu DX, Yu J and Wang F: Role of phosphorylated AMP-activated protein kinase (AMPK) in myocardial insulin resistance after myocardial ischemia-reperfusion during cardiopulmonary bypass surgery in dogs. Med Sci Monit. 25:4149–4158. 2019. View Article : Google Scholar : PubMed/NCBI

Zhou J, Massey S, Story D and Li L: Metformin: An old drug with new applications. Int J Mol Sci. 19:28632018. View Article : Google Scholar :

Chin JT, Troke JJ, Kimura N, Itoh S, Wang X, Palmer OP, Robbins RC and Fischbein MP: A novel cardioprotective agent in cardiac transplantation: Metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection. Yale J Biol Med. 84:423–432. 2011.PubMed/NCBI

Palee S, Higgins L, Leech T, Chattipakorn SC and Chattipakorn N: Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia / reperfusion injury. Biomed Pharmacother. 130:1106042020. View Article : Google Scholar : PubMed/NCBI

Holman RR, Paul SK, Bethel MA, Matthews DR and Neil HA: 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 359:1577–1589. 2008. View Article : Google Scholar : PubMed/NCBI

Mellbin LG, Malmberg K, Norhammar A, Wedel H and Rydé L; DIGAMI 2 Investigators: The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: A report from the DIGAMI 2 trial. Eur Heart J. 29:166–176. 2008. View Article : Google Scholar

Hartman MHT, Prins JKB, Schurer RAJ, Lipsic E, Lexis CPH, van der Horst-Schrivers ANA, van Veldhuisen DJ, van der Horst ICC and van der Harst P: Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: Data from the GIPS-III RCT. Clin Res Cardiol. 106:939–946. 2017. View Article : Google Scholar : PubMed/NCBI

Whitaker RM, Corum D, Beeson CC and Schnellmann RG: Mitochondrial biogenesis as a pharmacological target: A new approach to acute and chronic diseases. Annu Rev Pharmacol Toxicol. 56:229–249. 2016. View Article : Google Scholar

Kim H, Lee JY, Park KJ, Kim WH and Roh GS: A mitochondrial division inhibitor, Mdivi-1, inhibits mitochondrial fragmentation and attenuates kainic acid-induced hippocampal cell death. BMC Neurosci. 17:332016. View Article : Google Scholar : PubMed/NCBI

Veeranki S and Tyagi SC: Mdivi-1 induced acute changes in the angiogenic profile after ischemia-reperfusion injury in female mice. Physiol Rep. 5:e132982017. View Article : Google Scholar : PubMed/NCBI

Gao G, Chen W, Yan M, Liu J, Luo H, Wang C and Yang P: Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling. Int J Mol Med. 45:195–209. 2020.

Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP, Li YR and Li PF: miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med. 17:71–78. 2011. View Article : Google Scholar

Babot M, Birch A, Labarbuta P and Galkin A: Characterisation of the active/de-active transition of mitochondrial complex I. Biochim Biophys Acta. 1837:1083–1092. 2014. View Article : Google Scholar : PubMed/NCBI

Gorenkova N, Robinson E, Grieve DJ and Galkin A: Conformational change of mitochondrial complex I increases ROS sensitivity during ischemia. Antioxid Redox Signal. 19:1459–1468. 2013. View Article : Google Scholar : PubMed/NCBI

Chouchani ET, James AM, Methner C, Pell VR, Prime TA, Erickson BK, Forkink M, Lau GY, Bright TP, Menger KE, et al: Identification and quantification of protein S-nitrosation by nitrite in the mouse heart during ischemia. J Biol Chem. 292:14486–14495. 2017. View Article : Google Scholar : PubMed/NCBI

Pan J and Carroll KS: Light-mediated sulfenic acid generation from photocaged cysteine sulfoxide. Org Lett. 17:6014–6017. 2015. View Article : Google Scholar : PubMed/NCBI

Ukuwela AA, Bush AI, Wedd AG and Xiao Z: Reduction potentials of protein disulfides and catalysis of glutathionylation and deglutathionylation by glutaredoxin enzymes. Biochem J. 474:3799–3815. 2017. View Article : Google Scholar : PubMed/NCBI

Kolluru GK, Shen X and Kevil CG: Reactive sulfur species: A new redox player in cardiovascular pathophysiology. Arterioscler Thromb Vasc Biol. 40:874–884. 2020. View Article : Google Scholar : PubMed/NCBI

Davalli P, Mitic T, Caporali A, Lauriola A and D'Arca D: ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev. 2016:35651272016. View Article : Google Scholar : PubMed/NCBI

Shahzad S, Hasan A, Faizy AF, Mateen S, Fatima N and Moin S: Elevated DNA damage, oxidative stress, and impaired response defense system inflicted in patients with myocardial infarction. Clin Appl Thromb Hemost. 24:780–789. 2018. View Article : Google Scholar

Dey S, DeMazumder D, Sidor A, Foster DB and O'Rourke B: Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure. Circ Res. 123:356–371. 2018. View Article : Google Scholar : PubMed/NCBI

Gottlieb RA and Thomas A: Mitophagy and mitochondrial quality control mechanisms in the heart. Curr Pathobiol Rep. 5:161–169. 2017. View Article : Google Scholar : PubMed/NCBI

Guan R, Zou W, Dai X, Yu X, Liu H, Chen Q and Teng W: Mitophagy, a potential therapeutic target for stroke. J Biomed Sci. 25:872018. View Article : Google Scholar : PubMed/NCBI

Andres AM, Tucker KC, Thomas A, Taylor DJ, Sengstock D, Jahania SM, Dabir R, Pourpirali S, Brown JA, Westbrook DG, et al: Mitophagy and mitochondrial biogenesis in atrial tissue of patients undergoing heart surgery with cardio-pulmonary bypass. JCI Insight. 2:e893032017. View Article : Google Scholar

Moyzis AG, Sadoshima J and Gustafsson AB: Mending a broken heart: The role of mitophagy in cardioprotection. Am J Physiol Heart Circ Physiol. 308:H183–H192. 2015. View Article : Google Scholar :

Ding S, Wu D, Lu Q, Qian L, Ding Y, Liu G, Jia X, Zhang Y, Xiao W and Gong W: Angiopoietin-like 4 deficiency upregulates macrophage function through the dysregulation of cell-intrinsic fatty acid metabolism. Am J Cancer Res. 10:595–609. 2020.PubMed/NCBI

Cai J, Wang D, Zhao FQ, Liang S and Liu J: AMPK-mTOR pathway is involved in glucose-modulated amino acid sensing and utilization in the mammary glands of lactating goats. J Anim Sci Biotechnol. 11:322020. View Article : Google Scholar : PubMed/NCBI

Mackenzie RM, Salt IP, Miller WH, Logan A, Ibrahim HA, Degasperi A, Dymott JA, Hamilton CA, Murphy MP, Delles C and Dominiczak AF: Mitochondrial reactive oxygen species enhance AMP-activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetes. Clin Sci (Lond). 124:403–411. 2013. View Article : Google Scholar

Zhao Y, Shang F, Shi W, Zhang J, Liu X, Li B, Hu X and Wang L: Angiotensin II receptor type 1 antagonists modulate vascular smooth muscle cell proliferation and migration via AMPK/mTOR. Cardiology. 143:1–10. 2019. View Article : Google Scholar : PubMed/NCBI

Gerczuk PZ and Kloner RA: An update on cardioprotection: A review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol. 59:969–978. 2012. View Article : Google Scholar : PubMed/NCBI

Obtułowicz K: Bradykinin-mediated angioedema. Pol Arch Med Wewn. 126:76–85. 2016.

Taddei S and Bortolotto L: Unraveling the pivotal role of bradykinin in ACE inhibitor activity. Am J Cardiovasc Drugs. 16:309–321. 2016. View Article : Google Scholar : PubMed/NCBI

Lepelley M, Bernardeau C, Defendi F, Crochet J, Mallaret M and Bouillet L: Update on bradykinin-mediated angioedema in 2020. Therapie. 75:195–205. 2020. View Article : Google Scholar : PubMed/NCBI

Koh JQS, Fernando H, Peter K and Stub D: Opioids and ST elevation myocardial infarction: A systematic review. Heart Lung Circ. 28:697–706. 2019. View Article : Google Scholar : PubMed/NCBI

Tavenier AH, Hermanides RS, Ottervanger JP, Ter Horst PGJ, Kedhi E and van 't Hof AWJ: Risks of opioids in ST-elevation myocardial infarction: A review. Drug Saf. 41:1303–1308. 2018. View Article : Google Scholar : PubMed/NCBI

Jones SP, Tang XL, Guo Y, Steenbergen C, Lefer DJ, Kukreja RC, Kong M, Li Q, Bhushan S, Zhu X, et al: The NHLBI-sponsored consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): A new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ Res. 116:572–586. 2015. View Article : Google Scholar :